A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)
Trial details
- Registry ID
- NCT06108219
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as CORT118335
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)NCT06108219 | Corcept Therapeutics | Phase 2 | Completed | 2026-02-13Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |